Open Site Navigation
  • jocelyn981

Promising data for the treatment of Hurler MPS subtype


Orchard Therapeutics, a global gene therapy leader, announced data published in the New England Journal of Medicine (NEJM) evaluating the safety and efficacy of OTL-203 for the treatment of the Hurler subtype of Mucopolysaccharidosis type I (MPS-IH). Read more...

0 views

Canadian MPS Society

info@mpssociety.ca

Tel: 1-(604) 924-5130   Toll Free: 1-(800)-667-1846

#218-2055 Commercial Drive Vancouver, BC V5N OC7

  • Facebook
  • Twitter
  • LinkedIn

© Copyright 2021 Canadian MPS Society for Mucopolysaccharide & Related Diseases | All Rights Reserved.